indatuximab ravtansine immunomodulator antineoplastic antibodydrug conjugate chimerized mab linked maytansinoid investigated part treatment multiple preliminary data reported early stage clinical trial combination lenalidomide follow data reported encouraging efficacy december december clinical trials triple negative metastatic breast cancer metastatic urinary bladder highly overexpressed various solid tumors hematological malignancies represents one specific target antigens identification multiple myeloma mm antibody part binds target cells kills cellcitation needed monoclonal article stub help wikipedia expanding antineoplastic immunomodulatory drug article stub help wikipedia expanding ithttpsenwikipediaorgwikiindatuximabravtansine